Tag | Content |
---|
EnhancerAtlas ID | HS105-84939 |
Organism | Homo sapiens |
Tissue/cell | IMR90 |
Coordinate | chrX:64887720-64889580 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
RREB1 | MA0073.1 | chrX:64888485-64888505 | GAGTGGTGGTTGATTTGGGG | - | 6.79 | ZNF263 | MA0528.1 | chrX:64888146-64888167 | GAAGCAGGGAGAAAGGAGGGA | + | 6.37 | ZNF263 | MA0528.1 | chrX:64888362-64888383 | TTCTCCCTCCTCTCCACCTCC | - | 6.88 | Zfx | MA0146.2 | chrX:64887927-64887941 | CGGGGCGAGGCCTG | + | 6.67 |
|
| Number of super-enhancer constituents: 28 | ID | Coordinate | Tissue/cell |
SE_00139 | chrX:64886466-64903258 | Adipose_Nuclei | SE_02089 | chrX:64887478-64889531 | Aorta | SE_02753 | chrX:64886987-64889620 | Astrocytes | SE_09664 | chrX:64887058-64890770 | CD14 | SE_11087 | chrX:64886308-64928388 | CD20 | SE_18139 | chrX:64886827-64895399 | CD4p_CD25-_CD45ROp_Memory | SE_18347 | chrX:64886440-64902690 | CD4p_CD25-_Il17-_PMAstim_Th | SE_19204 | chrX:64886339-64895208 | CD4p_CD25-_Il17p_PMAstim_Th17 | SE_20433 | chrX:64887473-64890467 | CD56 | SE_22452 | chrX:64887436-64890648 | CD8_primiary | SE_25993 | chrX:64887424-64890324 | Duodenum_Smooth_Muscle | SE_35030 | chrX:64886388-64890493 | HeLa | SE_36819 | chrX:64887372-64890214 | HMEC | SE_37199 | chrX:64886821-64890719 | HSMMtube | SE_38193 | chrX:64886996-64895234 | HUVEC | SE_40903 | chrX:64886474-64890625 | Left_Ventricle | SE_42391 | chrX:64886373-64890613 | Lung | SE_44510 | chrX:64887255-64890197 | NHDF-Ad | SE_45176 | chrX:64887118-64889829 | NHLF | SE_46435 | chrX:64887209-64890255 | Osteoblasts | SE_50614 | chrX:64886833-64889657 | Sigmoid_Colon | SE_52105 | chrX:64887450-64889737 | Skeletal_Muscle_Myoblast | SE_53097 | chrX:64886960-64889562 | Small_Intestine | SE_54259 | chrX:64886834-64889566 | Spleen | SE_54931 | chrX:64886413-64889994 | Stomach_Smooth_Muscle | SE_59928 | chrX:64886386-64926160 | Ly4 | SE_62795 | chrX:64886580-64927676 | Tonsil | SE_63895 | chrX:64887440-64889787 | HSMM |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | GTGAGTGCCG GAGGTGGGCG CTGTCGACCC CAATGGCTCT GGCTGAGCCT CATAGCCCTT 60 TGCTGATGGC TGAGGGCTTG GCCAGCCACC GGCCCGCCTG GGACGCCGCG CCCTCCGCCA 120 TAGCCAAGGG TAGGGAGGGG ACCGGAGTGG GATCCTGGTC TGGTGCGCCC TCAGGGGTTG 180 AGGGGGTGTC CAGGCTGGAA GTTTGGACGG GGCGAGGCCT GCCTCTTTCT CAGGTTCCAG 240 TTCCCTGTGT CTGAGATGCA ACAGTCAGGA CGGCTTCGTT GGGGCCTGGG GTTTCCCCTT 300 TTCCCTGATG GGCCATGGGC ACAGAGGAGA GGATTCTGGT CCAGAAGACA ACACTTTCCC 360 CAACCCAGGA ATTGGCACCT TTCTGGGGCA AGGCTGCCAA TGTCCAAGAG GGGACATGGG 420 AACAGAGAAG CAGGGAGAAA GGAGGGAGCC GCTCGGGGCG GATCCGGCAC CCCCACTCAT 480 CTTTCCCACA GCCTCACCGG GTGGCTCCAG CTGTTTTCCA CTAGGAGGTG AGGAGAGAGA 540 TGTGAGGAAA TCGTCATCGA GGCTGCACCC GAGAGCACCA ACACTTATTT AGGCACCAGT 600 CTGAGGAGAG GCCTACCCCA TCTCCTGGGA GAGAGGACCG GTTTCTCCCT CCTCTCCACC 660 TCCAAATCCC TGCCCCTCCT ATTGCTTAAT GCCTCTCTAT CTCCTCCTAT CCCCTCCGGA 720 CTATTTTGTG TGGTGTGGGT TTTCTCGTGG GGCCACACCT TTCTAGAGTG GTGGTTGATT 780 TGGGGATGCG TCTCCACCCC ACTGGCTGTT ACGAGAGGAA CAGAAGCCTC CTGGGAGTGG 840 GGATAGGGGG GCCGGATGCC CAGGAGGGAG AGGGGAGGAG GGGTGTGCCT GACTAATGAG 900 CTCTGCTTGC TTTTGTGCAA GTCATGCCAA ATGGCTGCTG AGGCCCTTCC CTTGCTCAGA 960 AAGGCCTGGT GACCACCCTG GCTTGAGTCC CTTAGGCCAA ACAGCTTGTT GAGCTGGCCT 1020 AGGCAATGCA GTGCTCCCAA ACATGTCTCC CCAGGACTGC TTGAGCCTTG TAGAGGTGAG 1080 ATAGTGACTA GTAGCCTTGA AAAGGGCTGA AGGTCCCCTG GGATGAGAGG AGGAGAGTTG 1140 GGGGCCCAGC CTTTTGGGTT TGTGATGAGC TTTGGTTGCC ACGTTACTGT ATACCAGCCT 1200 CACTGCCAAG TCGTTCTTGC CTTTCCAGAA CCTTGTCCTT CAGAAACACC AAGTTTTCAA 1260 AAAGTATGTG CTTTCACTGT CTATCTCCTT TAAATTGCTT GTGGTTTTAG GACATGAGGC 1320 TTTTACACAC TTTGTTCCCT AGTCCCCGCC CCCAAAGAGA GAGAGTAATG GTTTTGGAGA 1380 GAGGGGAAAA TATCCCATTG TCTGCCAAAA CAAGATTATA AAGATCCTGT CAGGAGCGGC 1440 TCTTTGGGTC TCTCTCTGTG GTTGACTCCT GACTCCTCTT AAGGTGCGGC TTTGCCTGAA 1500 CAGTTGGGTG GATCTCTGGG AATAGACATT GCTCCACGGT CTTTCTTCTG TAGTGGCATA 1560 TCTCATCCTC AGTTCTGAGA TAGCCCACTT TGAAACACAG CTTCATGGGC CTGGAAGTTG 1620 CTTCAAACTT GCATTAACCG TCTCATCTGA GTCAAAGTGG CAAAGAAGAC AAGACAGCGT 1680 GTTTATTGTT TTCCTGGGAA TGGAGAGAGA ATGGAGTATA AGCTGTTTGT AGTCAGGCCT 1740 GGAGTAATGA GGGTACCTAA ATACTGAAGG CATTTTTATG CAGATTGACT GAAACCTGAA 1800 TCAAATTGGA AGGAGAGGGC TGAATTTTGA TAGACTGGAA GTATTAGAGA ATTTTCTATA 1860
|